GL1X · GenesisL1 explorer

Research workbench

Notum Inhibitor ARUK3004552

Analyse Notum Inhibitor ARUK3004552 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
8BTH
Type
protein
Length
356 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.3
Source
Homo sapiens
Molecule
Palmitoleoyl-protein carboxylesterase NOTUM
EC
3.1.1.98
UniProt
Q6P988
Ligands
RJ0, NAG, SO4
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · resolution 1.3 · 1 distinct chain · 33% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APalmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98)protein35633% helix, 18% strandQ6P988

Ligands and binding sites

  • RJ0 · 1-(2,3-dihydroindol-1-yl)prop-2-en-1-one · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • SO4 · Sulfate ion · ion · 5 copies · chains A
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1780.700.9417RJ0
21360.430.7619empty

Modifications

Observed in the structure: 7 disulfide, 1 glycan (disulfide, N-glycosylation).

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.